Fungal infections of the central nervous system in HIV-negative patients: experience from a tertiary referral center of South India.
OBJECTIVE
To describe the clinical, radiological, and cerebrovascular fluid (CSF) findings and the outcome of microbiologically or histopathologically proven fungal infections of the central nervous system (CNS) in HIV-negative patients.


RESULTS
We identified definite cases of CNS mycosis by screening the medical records of our institute for the period 2000-2008. The clinical and imaging details and the outcome were abstracted from the medical records and entered in a structured proforma. There were 12 patients with CNS mycosis (i.e., 2.7% of all CNS infections treated in this hospital); six (50%) had cryptococcal infection, three (25%) had mucormycosis, and two had unclassified fungal infection. Four (33%) of them had diabetes as a predisposing factor. The common presentations were meningoencephalitis (58%) and polycranial neuritis (41%). Magnetic resonance imaging revealed hydrocephalus in 41% and meningeal enhancement in 25%, as well as some unusual findings such as subdural hematoma in the bulbocervical region, carpeting lesion of the base of the skull, and enhancing lesion in the cerebellopontine angle. The CSF showed pleocytosis (66%), hypoglycorrhachia (83%), and elevated protein levels (100%). The diagnosis was confirmed by meningocortical biopsy (in three cases), paranasal sinus biopsy (in four cases), CSF culture (in three cases), India ink preparation (in four cases), or by cryptococcal polysaccharide antigen test (in three cases). Out of the ten patients for whom follow-up details were available, six patients recovered with antifungal medications (amphotericin B, 1 mg/kg/day for the minimum period of 6 weeks) and/or surgical treatment. Four patients expired (only one of them had received antifungal therapy).


CONCLUSIONS
Most patients with CNS mycosis recover with appropriate therapy, but the diagnosis and management of these rare infections remains a challenge to clinicians.
Ramesha
K N
KN
Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum-695 011, India.
Kate
Mahesh P
MP
Kesavadas
Chandrasekhar
C
Radhakrishnan
V V
VV
Nair
S
S
Thomas
Sanjeev V
SV
J Assoc Physicians India. 2000 Jul;48(7):677-81
11273500
Neurol India. 2007 Jul-Sep;55(3):233-40
17921652
Postgrad Med J. 2004 Nov;80(949):670-4
15537854
Indian J Med Sci. 2002 Jul;56(7):325-9
12645168
Clin Neuropharmacol. 1995 Apr;18(2):95-112
8635178
Neurol India. 2007 Jul-Sep;55(3):292-7
17921660
Intern Med. 1992 Feb;31(2):174-9
1600262
Neurol India. 2007 Jul-Sep;55(3):241-50
17921653
Neurology. 1985 Nov;35(11):1654-7
4058755
Mycoses. 2003 Jun;46(5-6):161-3
12801355
Neurol India. 2007 Jul-Sep;55(3):267-73
17921656
J Chin Med Assoc. 2003 Jan;66(1):19-26
12728970
Neurol India. 2003 Sep;51(3):364-6
14652440
Indian J Ophthalmol. 2003 Sep;51(3):231-6
14601848
Surg Neurol. 2005 Mar;63(3):254-60; discussion 260
15734518
Neurol India. 2007 Jul-Sep;55(3):251-9
17921654
Curr Opin Neurol. 2008 Jun;21(3):347-52
18451721